Primary prevention of sexually transmitted diseases. A primer for clinicians.
With the advent of sexually transmitted infections for which curative therapy is not available, primary prevention has assumed greater importance. The spectrum of sexually transmitted diseases (STDs) has broadened, and clinicians need to understand the mechanisms of their transmission and prevention. Modifying selection of sexual partners and avoiding certain sexual practices should theoretically reduce the risk of infection. Clinical and laboratory studies indicate that the use of condoms, diaphragms, and spermicides reduces the risk of acquiring certain infections. At present, hepatitis B is the only STD for which a safe, effective vaccine is available. Use of oral antibiotics cannot be recommended. Postcoital washing or urination have not been shown to have a protective effect against infection. Because of the potential benefits, persons at risk for STDs should be encouraged to modify their sexual behavior and use barrier methods and spermicides to protect themselves against sexually transmitted infections.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003273:Contraceptive Devices; D005260:Female; D006801:Humans; D008297:Male; D011322:Primary Prevention; D012725:Sexual Behavior; D012749:Sexually Transmitted Diseases / Q000517:prevention & control* / Q000635:transmission; D013089:Spermatocidal Agents
D000900:Anti-Bacterial Agents; D013089:Spermatocidal Agents